# ブレヤンジ静注

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4900406X1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4900406X1029
- **Product name (Japanese):** ブレヤンジ静注
- **Active ingredient:** リソカブタゲン マラルユーセル
- **Strength / unit:** １患者当たり
- **Route:** Injection (注射薬)
- **Therapeutic category:** 49 Other tissue and cell function agents (その他の組織細胞機能用医薬品)
- **Manufacturer:** Bristol Myers Squibb (ブリストル・マイヤーズ スクイブ)
- **NHI price (reference only):** JPY 35096343 per １患者当たり
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4900406X1029
- **JSON:** https://www.nifujipharma.com/api/drugs/4900406X1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=%E3%83%96%E3%83%AC%E3%83%A4%E3%83%B3%E3%82%B8%E9%9D%99%E6%B3%A8%20%2F%20YJ%204900406X1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.